
### [Orphanet:168491](http://www.orpha.net/ORDO/Orphanet_168491)
**Label:** Late infantile neuronal ceroid lipofuscinosis

**Subclasses:** [Orphanet:228354](http://www.orpha.net/ORDO/Orphanet_228354) (CLN8 disease), [Orphanet:228366](http://www.orpha.net/ORDO/Orphanet_228366) (CLN7 disease), [Orphanet:228360](http://www.orpha.net/ORDO/Orphanet_228360) (CLN5 disease), [Orphanet:228363](http://www.orpha.net/ORDO/Orphanet_228363) (CLN6 disease), [Orphanet:228329](http://www.orpha.net/ORDO/Orphanet_228329) (CLN1 disease), [Orphanet:228337](http://www.orpha.net/ORDO/Orphanet_228337) (CLN10 disease), [Orphanet:228349](http://www.orpha.net/ORDO/Orphanet_228349) (CLN2 disease), 

**Corr. equiv. classes:** [OMIM:600143](http://purl.obolibrary.org/obo/OMIM_600143), [Orphanet:228360](http://www.orpha.net/ORDO/Orphanet_228360), [OMIM:601780](http://purl.obolibrary.org/obo/OMIM_601780), [Orphanet:228363](http://www.orpha.net/ORDO/Orphanet_228363), [Orphanet:228354](http://www.orpha.net/ORDO/Orphanet_228354), [Orphanet:228366](http://www.orpha.net/ORDO/Orphanet_228366), [OMIM:256730](http://purl.obolibrary.org/obo/OMIM_256730), [OMIM:256731](http://purl.obolibrary.org/obo/OMIM_256731), [OMIM:204500](http://purl.obolibrary.org/obo/OMIM_204500), [OMIM:610951](http://purl.obolibrary.org/obo/OMIM_610951), [OMIM:610127](http://purl.obolibrary.org/obo/OMIM_610127), [Orphanet:228337](http://www.orpha.net/ORDO/Orphanet_228337), [Orphanet:228349](http://www.orpha.net/ORDO/Orphanet_228349), [Orphanet:228329](http://www.orpha.net/ORDO/Orphanet_228329), 

**Class expressions from DL-Learner:**

- [HP:0000572](http://purl.obolibrary.org/obo/HP_0000572) (Visual loss) and [HP:0001311](http://purl.obolibrary.org/obo/HP_0001311) (Abnormal nervous system electrophysiology) and [HP:0003205](http://purl.obolibrary.org/obo/HP_0003205) (Curvilinear intracellular accumulation of autofluorescent lipopigment storage material) 64.29%
- [HP:0000529](http://purl.obolibrary.org/obo/HP_0000529) (Progressive visual loss) and [HP:0001311](http://purl.obolibrary.org/obo/HP_0001311) (Abnormal nervous system electrophysiology) and [HP:0003205](http://purl.obolibrary.org/obo/HP_0003205) (Curvilinear intracellular accumulation of autofluorescent lipopigment storage material) 64.29%
- [HP:0000504](http://purl.obolibrary.org/obo/HP_0000504) (Abnormality of vision) and [HP:0001311](http://purl.obolibrary.org/obo/HP_0001311) (Abnormal nervous system electrophysiology) and [HP:0003205](http://purl.obolibrary.org/obo/HP_0003205) (Curvilinear intracellular accumulation of autofluorescent lipopigment storage material) 64.29%
- [HP:0001311](http://purl.obolibrary.org/obo/HP_0001311) (Abnormal nervous system electrophysiology) and [HP:0003205](http://purl.obolibrary.org/obo/HP_0003205) (Curvilinear intracellular accumulation of autofluorescent lipopigment storage material) and [HP:0011813](http://purl.obolibrary.org/obo/HP_0011813) (Increased cerebral lipofuscin) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) 64.29%
- [HP:0001311](http://purl.obolibrary.org/obo/HP_0001311) (Abnormal nervous system electrophysiology) and [HP:0003205](http://purl.obolibrary.org/obo/HP_0003205) (Curvilinear intracellular accumulation of autofluorescent lipopigment storage material) and [HP:0007367](http://purl.obolibrary.org/obo/HP_0007367) (Atrophy/Degeneration affecting the central nervous system) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) 64.29%
- [HP:0001311](http://purl.obolibrary.org/obo/HP_0001311) (Abnormal nervous system electrophysiology) and [HP:0002074](http://purl.obolibrary.org/obo/HP_0002074) (Increased neuronal autofluorescent lipopigment) and [HP:0003205](http://purl.obolibrary.org/obo/HP_0003205) (Curvilinear intracellular accumulation of autofluorescent lipopigment storage material) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) 64.29%
- [HP:0001311](http://purl.obolibrary.org/obo/HP_0001311) (Abnormal nervous system electrophysiology) and [HP:0002011](http://purl.obolibrary.org/obo/HP_0002011) (Morphological abnormality of the central nervous system) and [HP:0003205](http://purl.obolibrary.org/obo/HP_0003205) (Curvilinear intracellular accumulation of autofluorescent lipopigment storage material) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) 64.29%
- [HP:0001250](http://purl.obolibrary.org/obo/HP_0001250) (Seizures) and [HP:0001311](http://purl.obolibrary.org/obo/HP_0001311) (Abnormal nervous system electrophysiology) and [HP:0003205](http://purl.obolibrary.org/obo/HP_0003205) (Curvilinear intracellular accumulation of autofluorescent lipopigment storage material) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) 64.29%
- [HP:0000572](http://purl.obolibrary.org/obo/HP_0000572) (Visual loss) and [HP:0001311](http://purl.obolibrary.org/obo/HP_0001311) (Abnormal nervous system electrophysiology) and [HP:0003205](http://purl.obolibrary.org/obo/HP_0003205) (Curvilinear intracellular accumulation of autofluorescent lipopigment storage material) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 64.29%
- [HP:0000572](http://purl.obolibrary.org/obo/HP_0000572) (Visual loss) and [HP:0001311](http://purl.obolibrary.org/obo/HP_0001311) (Abnormal nervous system electrophysiology) and [HP:0003205](http://purl.obolibrary.org/obo/HP_0003205) (Curvilinear intracellular accumulation of autofluorescent lipopigment storage material) and [HP:0011813](http://purl.obolibrary.org/obo/HP_0011813) (Increased cerebral lipofuscin) 64.29%
- [HP:0000572](http://purl.obolibrary.org/obo/HP_0000572) (Visual loss) and [HP:0001311](http://purl.obolibrary.org/obo/HP_0001311) (Abnormal nervous system electrophysiology) and [HP:0003205](http://purl.obolibrary.org/obo/HP_0003205) (Curvilinear intracellular accumulation of autofluorescent lipopigment storage material) and [HP:0007367](http://purl.obolibrary.org/obo/HP_0007367) (Atrophy/Degeneration affecting the central nervous system) 64.29%
- [HP:0000572](http://purl.obolibrary.org/obo/HP_0000572) (Visual loss) and [HP:0001311](http://purl.obolibrary.org/obo/HP_0001311) (Abnormal nervous system electrophysiology) and [HP:0002074](http://purl.obolibrary.org/obo/HP_0002074) (Increased neuronal autofluorescent lipopigment) and [HP:0003205](http://purl.obolibrary.org/obo/HP_0003205) (Curvilinear intracellular accumulation of autofluorescent lipopigment storage material) 64.29%
- [HP:0000572](http://purl.obolibrary.org/obo/HP_0000572) (Visual loss) and [HP:0001311](http://purl.obolibrary.org/obo/HP_0001311) (Abnormal nervous system electrophysiology) and [HP:0002011](http://purl.obolibrary.org/obo/HP_0002011) (Morphological abnormality of the central nervous system) and [HP:0003205](http://purl.obolibrary.org/obo/HP_0003205) (Curvilinear intracellular accumulation of autofluorescent lipopigment storage material) 64.29%
- [HP:0000572](http://purl.obolibrary.org/obo/HP_0000572) (Visual loss) and [HP:0001250](http://purl.obolibrary.org/obo/HP_0001250) (Seizures) and [HP:0001311](http://purl.obolibrary.org/obo/HP_0001311) (Abnormal nervous system electrophysiology) and [HP:0003205](http://purl.obolibrary.org/obo/HP_0003205) (Curvilinear intracellular accumulation of autofluorescent lipopigment storage material) 64.29%
- [HP:0000529](http://purl.obolibrary.org/obo/HP_0000529) (Progressive visual loss) and [HP:0001311](http://purl.obolibrary.org/obo/HP_0001311) (Abnormal nervous system electrophysiology) and [HP:0003205](http://purl.obolibrary.org/obo/HP_0003205) (Curvilinear intracellular accumulation of autofluorescent lipopigment storage material) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 64.29%


